Mersana Therapeutics, Inc. 0M4.F Stock
Mersana Therapeutics, Inc. Price Chart
Mersana Therapeutics, Inc. 0M4.F Financial and Trading Overview
| Mersana Therapeutics, Inc. stock price | 2.46 EUR |
| Previous Close | 6.5 EUR |
| Open | 8.76 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 3.6 - 3.6 EUR |
| 52 Week Range | 2.96 - 8.7 EUR |
| Volume | 500 EUR |
| Avg. Volume | 25 EUR |
| Market Cap | 450.63M EUR |
| Beta (5Y Monthly) | 1.695422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.67 EUR |
0M4.F Valuation Measures
| Enterprise Value | 724.43M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.5450643 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.931122 |
| Price/Book (mrq) | 6.101695 |
| Enterprise Value/Revenue | 22.396 |
| Enterprise Value/EBITDA | -3.386 |
Trading Information
Mersana Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.695422 |
| 52-Week Change | 193.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.7 EUR |
| 52 Week Low | 2.96 EUR |
| 50-Day Moving Average | 5.16 EUR |
| 200-Day Moving Average | 5.89 EUR |
0M4.F Share Statistics
| Avg. Volume (3 month) | 25 EUR |
| Avg. Daily Volume (10-Days) | 135 EUR |
| Shares Outstanding | 114.39M |
| Float | 87.83M |
| Short Ratio | N/A |
| % Held by Insiders | 1.23% |
| % Held by Institutions | 99.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -664.71% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.47% |
| Return on Equity (ttm) | -208.10% |
Income Statement
| Revenue (ttm) | 32.35M EUR |
| Revenue Per Share (ttm) | 0.32 EUR |
| Quarterly Revenue Growth (yoy) | 283.19% |
| Gross Profit (ttm) | -146804000 EUR |
| EBITDA | -213975008 EUR |
| Net Income Avi to Common (ttm) | -213116992 EUR |
| Diluted EPS (ttm) | -1.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 273.92M EUR |
| Total Cash Per Share (mrq) | 2.4 EUR |
| Total Debt (mrq) | 35.68M EUR |
| Total Debt/Equity (mrq) | 55.5 EUR |
| Current Ratio (mrq) | 3.379 |
| Book Value Per Share (mrq) | 0.59 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -70413000 EUR |
| Levered Free Cash Flow (ttm) | -85725872 EUR |
Profile of Mersana Therapeutics, Inc.
| Country | Germany |
| State | MA |
| City | Cambridge |
| Address | 840 Memorial Drive |
| ZIP | 02139 |
| Phone | 617 498 0020 |
| Website | https://www.mersana.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 228 |
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has a research and development collaborations with Janssen Biotech, Inc. and Merck KGaA, as well as collaboration agreement with Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Q&A For Mersana Therapeutics, Inc. Stock
What is a current 0M4.F stock price?
Mersana Therapeutics, Inc. 0M4.F stock price today per share is 2.46 EUR.
How to purchase Mersana Therapeutics, Inc. stock?
You can buy 0M4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mersana Therapeutics, Inc.?
The stock symbol or ticker of Mersana Therapeutics, Inc. is 0M4.F.
Which industry does the Mersana Therapeutics, Inc. company belong to?
The Mersana Therapeutics, Inc. industry is Biotechnology.
How many shares does Mersana Therapeutics, Inc. have in circulation?
The max supply of Mersana Therapeutics, Inc. shares is 128.6M.
What is Mersana Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Mersana Therapeutics, Inc. PE Ratio is now.
What was Mersana Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Mersana Therapeutics, Inc. EPS is -1.03 EUR over the trailing 12 months.
Which sector does the Mersana Therapeutics, Inc. company belong to?
The Mersana Therapeutics, Inc. sector is Healthcare.